I'll bet the ASX can't knock this one! - >$12 million in cash at the end of the quarter and as the company announced the US instos are right behind these guys. Additional proof is that US Insto's exercised their options in Immunology to the tune of $2.5 million when they were effectively out of the money. Tell me that's not support and faith in a company, its Board and management!
It looks to me as if the cash burn of the Company is coming down too. It was suggested to me by the company after the last quarterly report that the costs would come down over the coming months and it looks like this program is starting.
It sounds like its time for everyone to listen to Thymus, Dolphin et. al.
Add to My Watchlist
What is My Watchlist?